WARPTECHNEWS · LAB

Home AI Business Tech Archive

Storia: Moderna says skin cancer vaccine trial a success — Warptech Lab News

Storia in 19 fonti

Moderna says skin cancer vaccine trial a success

The experimental vaccine successfully reduced the recurrence of melanoma, the company said

Raccontata da

timesofisrael.com

en.mercopress.com

biopharmadive.com

axios.com+7 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

theweek.comStai leggendo3 h fa

Moderna says skin cancer vaccine trial a success

The experimental vaccine successfully reduced the recurrence of melanoma, the company said

Timeline cronologica

mercoledì 19 agosto 2026·timesofisrael.com
‘Breakthrough’ Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence
News of first positive large late-stage trial result for drug could signal new era for treating solid-tumor cancers, with tests underway for lung, breast and pancreatic cancers
mercoledì 19 agosto 2026·en.mercopress.com
A personalized mRNA therapy passes a phase 3 melanoma trial for the first time
Pharmaceutical companies Merck, known as MSD outside the United States and Canada, and Moderna announced on Wednesday that their individualized neoantigen therapy, intismeran…

21 h fa

‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say

Moderna and Merck said the personalised vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment.

Leggi questa versione → originale

nature.com18 h fa

Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?

Promising trial results suggest cancer vaccines work and could be used to target other tumours.

Leggi questa versione → originale

huffpost.com21 h fa

New Cancer Treatment Hope After mRNA Vaccine Success

The companies — and others — are testing similar approaches against lung, breast and pancreatic cancers.

Leggi questa versione → originale

timesofisrael.com1 g fa

‘Breakthrough’ Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence

News of first positive large late-stage trial result for drug could signal new era for treating solid-tumor cancers, with tests underway for lung, breast and pancreatic cancers

Leggi questa versione → originale

cbc.ca1 g fa

Merck, Moderna say melanoma vaccine meets goals in large trial | CBC News

Merck and Moderna report that a personalized mRNA vaccine helped prevent skin cancer from returning in high-risk patients. Observers greeted the news with enthusiasm but noted that full data from the ongoing late-stage…

Leggi questa versione → originale

mercoledì 19 agosto 2026·

biopharmadive.com

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna…

mercoledì 19 agosto 2026·

france24.com

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

US drugmakers Merck and Moderna said Wednesday a personalized cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by…

mercoledì 19 agosto 2026·

cbc.ca

Merck, Moderna say melanoma vaccine meets goals in large trial | CBC News

Merck and Moderna report that a personalized mRNA vaccine helped prevent skin cancer from returning in high-risk patients. Observers greeted the news with enthusiasm but noted…

mercoledì 19 agosto 2026·

dailymail.com

'Landmark moment' as vaccine stops cancer returning in striking trial

A new personalised vaccine could halve the risk of skin cancer returning in high-risk patients, a large trial has found.

mercoledì 19 agosto 2026·

news.com.au

‘First time’: Drug giants’ cancer breakthrough

US drugmakers Merck and Moderna said Wednesday an experimental melanoma drug that delivers treatment tailored to a patient’s specific tumour prevented the cancer from returning in…

mercoledì 19 agosto 2026·

elcomercio.pe

¿Cómo es la vacuna contra el cáncer de piel de Moderna y por qué ha sacudido los mercados?

El tratamiento experimental se administra tras la cirugía y busca reducir el riesgo de recaída y metástasis en pacientes con melanoma.

mercoledì 19 agosto 2026·

virgilio.it

Moderna annuncia risultati sul vaccino mRna contro il melanoma, superato test di fase 3 su cancro della pelle

Moderna e Merck hanno annunciato i risultati positivi sul vaccino a mRna contro il melanoma dai test di fase 3 su 1.100 pazienti con cancro della pelle

mercoledì 19 agosto 2026·

fortune.com

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks…

The shot, paired with Merck's Keytruda, cut the risk of melanoma recurrence in a trial of more than 1,100 patients.

mercoledì 19 agosto 2026·

spiegel.de

Moderna: Erfolgreiche Studie zu Hautkrebs-Impfstoff beflügelt Börsenkurs

Mit seinen Covid-Vakzinen machte das US-Pharmaunternehmen Moderna sich weltweit einen Namen. Nun hofft es, mit einem Vakzin gegen Hautkrebs daran anknüpfen zu können. Eine Studie…

mercoledì 19 agosto 2026·

axios.com

Moderna and Merck shares soar on mRNA cancer vaccine

The results come at a pivotal moment for Moderna and mRNA research.

mercoledì 19 agosto 2026·

huffpost.com

New Cancer Treatment Hope After mRNA Vaccine Success

The companies — and others — are testing similar approaches against lung, breast and pancreatic cancers.

mercoledì 19 agosto 2026·

larepublica.pe

Moderna y Merck anuncian el éxito de su vacuna contra el melanoma tras un ensayo con resultados prometedores

El tratamiento combina una estrategia diseñada según las mutaciones de cada tumor con una inmunoterapia que ayuda al organismo a reconocer y atacar las células cancerosas.

mercoledì 19 agosto 2026·

aljazeera.com

Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.

mercoledì 19 agosto 2026·

smh.com.au

‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say

Moderna and Merck said the personalised vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment.

giovedì 20 agosto 2026·

afr.com

Moderna shares nearly triple on skin cancer vaccine success

The experimental therapy, jointly developed with Merck, would be unprecedented in cancer treatment, providing a custom-made vaccine for each patient.

giovedì 20 agosto 2026·

huffpost.com

New Melanoma Vaccine Shows Promise In Fighting Cancer, Preventing Recurrence

“It’s very exciting,” a melanoma expert said of the experimental cancer vaccine announced by pharmaceutical companies Moderna and Merck.

giovedì 20 agosto 2026·

nature.com

Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?

Promising trial results suggest cancer vaccines work and could be used to target other tumours.

giovedì 20 agosto 2026·

thehindubusinessline.com

Moderna, Merck breakthrough could usher in a wave of cancer vaccines

Merck and Moderna’s personalized mRNA cancer vaccine helps prevent melanoma recurrence and spread, raising hopes for use against other cancers.

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com